Markets.com Logo

ACRXF

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    12.0209$
  • Previous Close
    12.0209$
  • 52 Week Change
    4.24$
  • Day Range
    0.00$
  • 52 Week High/Low
    8.0764$ - 12.318$
  • Dividend Per Share
    0.052
  • Market cap
    3 116 M$
  • EPS
    0.1398
  • Beta
    1.107
  • Volume
    --

About

ACRXF.US represents the over-the-counter (OTC) traded stock of AcelRx Pharmaceuticals, Inc. in the United States. AcelRx Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Their product pipeline has included pain management solutions. Trading on the OTC market typically indicates the company may not meet the listing requirements of major exchanges like the NYSE or NASDAQ, often due to factors such as lower market capitalization or financial performance. Investors should be aware that OTC stocks generally carry higher risks and may have lower liquidity compared to stocks listed on major exchanges.

US Jobs Report and Fed Policy Outlook: Market Expectations and Potential Risks

Sophia Claire|--

Central Banks' Gold Rush: Why They're Piling into the Precious Metal

Liam James|--
GME stock is trading down: What is the target price for GME stock in 2025?

GME stock is trading down: What is the target price for GME stock in 2025?

Ghko B|--
RGTI Stock Price Analysis: Why Rigetti (RGTI) Stock Is Trading Higher Today?

RGTI Stock Price Analysis: Why Rigetti (RGTI) Stock Is Trading Higher Today?

Ghko B|--
XRP Price Prediction: Can Ripple (XRP/USD) Reach $4 in 2025?

XRP Price Prediction: Can Ripple (XRP/USD) Reach $4 in 2025?

Ghko B|--

Apple iPhone 17 Price Speculation & New Devices: A Closer Look at Projections

Sophia Claire|--

Goldman Sachs: Gold Could Hit $5,000 if Fed Credibility Falters

Ava Grace|--

Factors

Acorda Therapeutics' Stock Price Drivers (ACRXF.US): Market Sentiment: Overall investor confidence and risk appetite impact demand. Positive market trends can lift the stock, while fear can depress it. Financial Performance: Revenue, profitability, and earnings growth significantly influence investor perception. Strong financials typically boost the price. Drug Pipeline Progress: Clinical trial results, FDA approvals, and regulatory milestones for Acorda's pipeline drugs have a direct effect. Positive news increases stock value. Competition: The presence and success of competing drugs can diminish Acorda's market share and revenue potential, impacting the stock negatively. Debt Levels and Cash Flow: Acorda's financial health, including its debt burden and ability to generate cash, is crucial. High debt and weak cash flow can pressure the stock. Overall Pharmaceutical Industry Trends: Trends in the pharmaceutical industry, such as changes in regulations, pricing pressures, and innovation, affect Acorda. Economic Conditions: General economic factors, including inflation, interest rates, and economic growth, indirectly influence investor behavior and Acorda's business environment. Management Decisions: Strategic decisions made by Acorda's management team, such as acquisitions, partnerships, and research investments, impact the stock's long-term prospects.

People Also Watch

Latest news

US Job Growth Slows, Unemployment Rises: Rate Cut Outlook Intensifies

Noah Lee|--

Global Market Overview: Weak Nonfarm Data, Gold Hits Highs, OPEC+ Considers Output Hike

Emma Rose|--

US Job Growth Slows, Unemployment Rises: Fed Rate Cut Expectations Surge

Emma Rose|--

Latest Education Articles

Indices CFD Trading for beginner: Dow Jones Index, S&P 500, Nasdaq Index

Indices CFD Trading for beginner: Dow Jones Index, S&P 500, Nasdaq Index

Frances Wang|--
SoFi Technologies Inc Stock Is Rising: How to Trade Sofi Stock CFDs?

SoFi Technologies Inc Stock Is Rising: How to Trade Sofi Stock CFDs?

Frances Wang|--
Crypto CFD Trading Benefits and Risks: Ethereum, XRP, Dogecoin

Crypto CFD Trading Benefits and Risks: Ethereum, XRP, Dogecoin

Ghko B|--